<DOC>
	<DOCNO>NCT00355056</DOCNO>
	<brief_summary>The Purpose study evaluate impact percutaneous closure patent foramen ovale ( hole heart ) , use AMPLATZER PFO Occluder , incidence migraine headache .</brief_summary>
	<brief_title>Premium Migraine Trial</brief_title>
	<detailed_description>The objective study evaluate whether percutaneous PFO closure effective reduce incidence disable migraine headache patient refactory medical treatment .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Foramen Ovale , Patent</mesh_term>
	<criteria>Subjects diagnose migraine headache without aura Have Patent Foramen Ovale ( PFO ) A migraine history show refractoriness medical treatment Willing participate followup visit Subjects whose primary headache migraine headache Who overuse migraine treatment With clinical history stroke Transient Ischemic Attack ( TIA ) With contraindication aspirin therapy Clopidogrel Pregnant desire become pregnant within next year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Migraine</keyword>
	<keyword>PFO</keyword>
	<keyword>Migraine Headache</keyword>
	<keyword>patent foramen ovale</keyword>
</DOC>